Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy
Clinical trial NCT06443606 · RECRUITING
Trial details
- NCT number
- NCT06443606
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-27
- Primary completion
- 2027-12-30
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.